Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to assess the safety and efficacy of the HemCon GuardaCareXR compared to standard bandaging in subjects with post partum hemorrhage as a result of cervical and vaginal lacerations. The primary endpoint will be a cessation of bleeding at 30 minutes after insertion of the dressing.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01373801
Study type Interventional
Source Soroka University Medical Center
Contact Arnon Wiznitzer, MD
Phone 972-8-6400774
Email arnonw@clalit.org.il
Status Recruiting
Phase N/A
Start date July 2011

See also
  Status Clinical Trial Phase
Recruiting NCT02495272 - Postpartum Uterotonic Administration N/A
Completed NCT01954186 - When and How to Administer Oxytocin for Active Management of Third Stage of Labour N/A